Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.

Accepted version
Repository URI
https://www.repository.cam.ac.uk/handle/1810/292422
Repository DOI
https://doi.org/10.17863/CAM.39579
Files
Accepted version (408.26 KB)
Supporting information (572.58 KB)
Type
Article
Change log
Authors
Barone, Martina 
Ricci, Francesca 
Sollazzo, Daria 
Ottaviani, Emanuela 
Romano, Marco 
Show 5 more
Description
Keywords
essential thrombocythaemia, megakaryocytopoiesis, microvesicles, myelofibrosis, platelet activation, ruxolitinib, Blood Platelets, Female, Humans, Janus Kinases, Male, Megakaryocytes, Nitriles, Primary Myelofibrosis, Pyrazoles, Pyrimidines
Journal Title
Br J Haematol
Conference Name
Journal ISSN
0007-1048
1365-2141
Volume Title
185
Publisher
Wiley
Publisher DOI
https://doi.org/10.1111/bjh.15682
Rights
All rights reserved
Sponsorship
Italian Association for Cancer Research (AIRC) (Fellowship Rif. 20930)
Medical Research Council (MC_PC_12009)
Collections
Cambridge University Research Outputs